European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 431-438, May 2010

Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer

  • N.-P. Tang

      Affiliations

    • National Shanghai Center for New Drug Safety Evaluation and Research, Shanghai institute of pharmaceutical industry, 199 Guoshoujing Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, PR China
    • Corresponding Author InformationCorresponding author. Tel.: +86 21 50800333; fax: +86 21 50801259.
    • ,
  • Y.-M. Wu

      Affiliations

    • Department of General Surgery, People's Hospital of Liyang City, Liyang, Jiangsu Province, PR China
    • ,
  • B. Wang

      Affiliations

    • Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu Province, PR China
    • ,
  • J. Ma

      Affiliations

    • National Shanghai Center for New Drug Safety Evaluation and Research, Shanghai institute of pharmaceutical industry, 199 Guoshoujing Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203, PR China

Accepted 22 March 2010.

Abstract 

Background

A number of studies has evaluated the association between P53 codon 72 polymorphism and colorectal cancer. However, results were inconsistent. To clarify the role of this polymorphism in colorectal cancer, we conducted a meta-analysis on this topic.

Methods

Two authors independently searched the PubMed and EMBASE database from 1966 to January 2010 for studies regarding the association of P53 codon 72 polymorphism with colorectal cancer. Summary odds ratios with their corresponding 95% confidence intervals were calculated by using random-effects model.

Results

The combined results showed that P53 codon 72 variant genotypes were not associated with colorectal cancer risk when compared to Arg/Arg genotype (Pro/Pro: OR = 1.02, 95% CI = 0.80–1.29; Arg/Pro: OR = 1.00, 95% CI = 0.86–1.16; Pro allele: OR = 1.00, 95% CI = 0.86–1.17). When stratifying for study population, design and cancer location, no statistically significant results were observed either.

Conclusion

Our data indicate that the P53 codon 72 polymorphism may be not associated with colorectal cancer risk.

Keywords: Colorectal cancer, P53 codon 72, Polymorphism, Meta-analysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(10)00066-1

doi:10.1016/j.ejso.2010.03.010

European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 431-438, May 2010

Article Tools

* Image Usage & Resolution